John Minardo
Chief Legal Officer
John Minardo has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Mar 12, 2026.
On the most recent filing, John Minardo is listed as Chief Legal Officer at IRONWOOD PHARMACEUTICALS INC. Inside the rolling window, John Minardo reported no open-market purchases and 2 open-market sales totaling $136K in IRWD. The largest disclosed transaction in the window is a sale of 19,053 IRWD shares on Feb 24, 2026, worth $70K.
Companies traded
Other insiders at IRWD
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$136K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has John Minardo made?
John Minardo has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company since 2026.
Which companies does John Minardo trade?
John Minardo has filed SEC Form 4 disclosures for 1 company, including IRWD.
When was John Minardo's most recent SEC Form 4 filing?
John Minardo's most recent SEC Form 4 filing on Tracefour is dated Mar 12, 2026.
What is John Minardo's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, John Minardo is listed as Chief Legal Officer.
What is John Minardo's total buy and sell value in the current window?
Inside the rolling retention window, John Minardo bought $0 and sold $136K based on SEC Form 4 filings.
What was John Minardo's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 19,053 IRWD shares on 2026-02-24, worth $70K, per SEC Form 4 filings.